drugset / Trial / NCT02160626

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

NCT02160626

Phase 2 Completed 172 enrolled Aclaris Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101 solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle.

Timeline

Start
2014-06
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrogen Peroxide Small molecule 32.5 unknown Topical
Comparator Hydrogen Peroxide Small molecule 40 unknown Topical

Indications